本期内容提示:
1、此前推的逆向并购概念股$Aerpio制药(ARPO)$ 宣布了并购,后续是否还有行情?哪些标的还有类似的潜力?
2、又一双抗药物平台获得多家机构建仓,是否有投资机会?
3、$Seelos Therapeutics(SEEL)$ 数据不错,缘何大跌,是否有抄底机会...查看全文
Seelos Therapeutics盘前跌4.25%,报0.153美元。消息上,在Seelos Therapeutics公布了SLS-002治疗抑郁症的2期临床试验数据后,Cantor Fitzgerald将该公司的评级从“增持”下调至“中性”,同时没有... 网页链接
$Seelos Therapeutics(SEEL)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-19-002729 Act: 33 Size: 1 KB 网页链接
$Seelos Therapeutics(SEEL)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001136261-19-000276 Act: 33 Size: 125 KB 网页链接
$Seelos Therapeutics(SEEL)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001136261-19-000270 Act: 33 Size: 682 KB 网页链接
$Seelos Therapeutics(SEEL)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-07 AccNo: 0001136261-19-000264 Size: 3 MB 网页链接
$Seelos Therapeutics(SEEL)$ 8-K - Current report Filed: 2019-11-07 AccNo: 0001136261-19-000265 Size: 14 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Seelos Therapeutics(SEEL)$ 8-K - Current report Filed: 2019-10-21 AccNo: 0001136261-19-000239 Size: 45 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Seelos Therapeutics(SEEL)$ D - Notice of Exempt Offering of Securities Filed: 2019-08-30 AccNo: 0001017491-19-000002 Size: 11 KB 网页链接
$Seelos Therapeutics(SEEL)$ 8-K - Current report Filed: 2019-08-27 AccNo: 0001136261-19-000232 Size: 425 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits 网页链接
$Seelos Therapeutics(SEEL)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-08-26 AccNo: 0001136261-19-000228 Size: 355 KB 网页链接
$Seelos Therapeutics(SEEL)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-08-23 AccNo: 0001136261-19-000225 Size: 13 KB 网页链接